Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.6 USD | +2.56% | -5.08% | -10.70% |
Financials (USD)
Sales 2022 | 42.01M | Sales 2023 | 39.55M | Capitalization | 26.7M |
---|---|---|---|---|---|
Net income 2022 | -5M | Net income 2023 | -6M | EV / Sales 2022 | 0.8 x |
Net Debt 2022 | 1.2M | Net Debt 2023 | 107K | EV / Sales 2023 | 0.68 x |
P/E ratio 2022 |
-5.88
x | P/E ratio 2023 |
-4.07
x | Employees | 91 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 55.94% |
Latest transcript on Cumberland Pharmaceuticals Inc.
1 day | +2.56% | ||
1 week | -5.08% | ||
Current month | -4.76% | ||
1 month | -14.44% | ||
3 months | -18.78% | ||
6 months | -20.79% | ||
Current year | -10.70% |
Managers | Title | Age | Since |
---|---|---|---|
A. Kazimi
CEO | Chief Executive Officer | 65 | 99-01-06 |
John Hamm
DFI | Director of Finance/CFO | 67 | 18-12-31 |
James Herman
CMP | Compliance Officer | 67 | 02-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Martin Brown
BRD | Director/Board Member | 59 | 22-07-14 |
A. Kazimi
CEO | Chief Executive Officer | 65 | 99-01-06 |
Ken Krogulski
BRD | Director/Board Member | 66 | 17-01-17 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-17 | 1.6 | +2.56% | 4 508 |
24-04-16 | 1.56 | +0.65% | 17,965 |
24-04-15 | 1.55 | -4.91% | 2,876 |
24-04-12 | 1.63 | -2.98% | 1,023 |
24-04-11 | 1.68 | -0.33% | 3,526 |
Delayed Quote Nasdaq, April 17, 2024 at 12:39 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-10.70% | 22.12M | |
+22.08% | 44.09B | |
+18.38% | 22.25B | |
+10.34% | 13.27B | |
+3.70% | 13.15B | |
+37.09% | 11.36B | |
-7.53% | 7.16B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+9.79% | 5.22B |
- Stock Market
- Equities
- CPIX Stock